RemeGen Co., Ltd. (REGMF) Stock Overview
Explore RemeGen Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
RemeGen Co., Ltd. (REGMF)
Key Financials
Key Financials
Market Cap
6.8B
P/E Ratio
35.98
EPS (TTM)
$0.19
ROE
0.42%
REGMF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of RemeGen Co., Ltd. (REGMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 53.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.98 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.